Lawmakers in Virginia are pushing for the creation of a Prescription Drug Affordability Board to protect state residents and healthcare stakeholders from high drug costs.[1][6] The board must meet in public at least four times a year, members must disclose conflicts of interest, and the board has the support of the board's stakeholders in decision-making.[1] The board will conduct affordability reviews of select drugs sold in Virginia and set payment caps for those it determines to be unaffordable.[1][7] These limits apply to state-sponsored and regulated health plans as of December 31, 2026.[1] The legislation has a fiscal impact: $350,000 in the first year and $644,000 in the second year from the general fund are proposed for its implementation.[9] The Virginia Senate passed SB 271 and the House HB 483 to establish this board with the authority to set payment caps.[1][5][7] According to proponents, this is a new approach that goes further than efforts in other states such as Washington or Colorado.[1][3]